While I share your hopes, there are still plenty of things to worry about with Nyrada.
1. If AGN's ARG-002 shows promise in their upcoming P2 results, it might negate any need for NYR's asset. If primary brain injury is reduced, secondary injury is naturally reduced as well. 2. Millions of $0.075 NOX shares are now free on the market... Must be tempting to flip them now for a quick 100%. 3. No US patent has been granted... The IP is not locked in.
NYR Price at posting:
15.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)